News

KNG: Enhancing Dividend Aristocrat Yields With Covered Calls

4 Mins read

This article series aims at evaluating ETFs (exchange-traded funds) regarding the relative past performance of their strategies and metrics of their current portfolios. Reviews with updated data are posted when necessary.

KNG strategy and portfolio

Ticker

Name

Weight%

EPS growth %TTM

P/E TTM

P/E fwd

Yield%

GD

General Dynamics Corp.

1.85%

3.15

19.48

18.77

2.22

AFL

Aflac Incorporated

1.83%

12.66

10.69

13.19

2.10

ABBV

AbbVie Inc.

1.73%

-31.10

30.46

13.39

3.99

CB

Chubb Ltd.

1.73%

-16.01

15.04

11.23

1.64

ADP

Automatic Data Processing, Inc.

1.72%

17.19

30.17

27.09

2.02

CAT

Caterpillar Inc.

1.72%

28.61

16.77

13.50

1.93

EMR

Emerson Electric Co.

1.72%

-105.42

N/A

21.55

2.17

WST

West Pharmaceutical Services, Inc.

1.71%

-23.90

56.10

49.06

0.20

IBM

International Business Machines Corp.

1.69%

-64.96

65.50

14.75

4.70

ROP

Roper Technologies, Inc.

1.69%

12.89

43.01

30.43

0.54

KNG

SPY

Price / Earnings TTM

21.08

21.48

Price / Book

3.43

3.81

Price / Sales

1.43

2.44

Price / Cash Flow

14.28

15.07

KNG

SPY

Altman Z-score

4.16

3.45

Piotroski F-score

5.9

5.64

ROA % TTM

7.51

7.1

Read the full article here

Related posts
News

ZTR: Hybrid Portfolio With Utility Tilt At A Deep Discount (NYSE:ZTR)

1 Mins read
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds…
News

IJT ETF: Why The Tide May Turn For Small-Cap Growth In 2026 (NASDAQ:IJT)

1 Mins read
This article was written by Follow The Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background,…
News

Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and Growth Hormone in Achondroplasia Transcript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *